In C. elegans , the
clk-1 gene product controls lifespan and many physiological rates, such as defecation, pharyngeal pumping, and movement, and the length of embryonic and post-embryonic development.
clk-1 encodes a 187 amino acid protein localized in mitochondria (Branicky et al. , 2000). Interestingly, the
clk-1 homolog in yeast,
coq7 , is implicated in the synthesis of ubiquinone (Q), an important electron transporter especially in mitochondria. Recently, the involvment of CLK-1 in Q biosynthesis in C. elegans has been demonstrated by the finding that
clk-1 mutants do not synthesize Q (Jonassen et al. , 2000, Miyadera et al. , 2001). Rather, they accumulate demethoxyubiquinone (DMQ), which is a Q synthesis intermediate able to sustain mitochondrial respiration in vitro , such that mutant mitochondria have almost wild-type levels of electron transport despite a complete absence of Q (Miyadera et al. , 2001). Only DMQ is present in all three
clk-1 alleles irrespective of the severity of their effect on physiological rates, which suggests that the lack of Q cannot solely account for the Clk phenotype. Recently it has also been found that
clk-1 mutants are unable to grow on a Q-deficient bacterial strain (Jonassen et al. , 2000). This seems to indicate that the endogenous Q manufactured by the bacteria on which the worms are grown, is capable of complementing some key cellular process that requires Q. Alternatively, it could be that
clk-1 mutants cannot grow on Q-deficient strains because of the imbalanced metabolism of these strains, which could result in an accumulation of compounds that are selectively detrimental to the
clk-1 mutants. In order to better understand the impact of Q metabolism on
clk-1 , we are systematically evaluating the behavior of Clk worms, when fed with bacteria deficient in each of the genes implicated in Q biosynthesis in E. coli ( ubi genes). We will also evaluate the effect of exogenous Qs, fed to the live worms. Finally, we will investigate the status of ubi homologs in Clk mutants, at the mRNA and the protein level. This approach will help to understand how the ubiquinone biosynthesis defect relates to the Clk phenotype: whether it causes the pleiotropy of
clk-1 mutants, or whether it is one of their pleiotropic features. References: Branicky et al. (2000), BioEssays; 22: 48-56 Jonassen et al. (2000), Proc. Natl. Acad. Sci. U S A.; 98: 421-426 Miyadera et al. (2001), J. Biol. Chem.; 276: 7713-7716